These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32838178)

  • 1. Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19.
    Pourahmad R; Moazzami B; Rezaei N
    SN Compr Clin Med; 2020; 2(9):1407-1411. PubMed ID: 32838178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of plasmapheresis and intravenous immunoglobulin as maintenance therapies for juvenile myasthenia gravis.
    Liew WK; Powell CA; Sloan SR; Shamberger RC; Weldon CB; Darras BT; Kang PB
    JAMA Neurol; 2014 May; 71(5):575-80. PubMed ID: 24590389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019.
    Cao W; Liu X; Bai T; Fan H; Hong K; Song H; Han Y; Lin L; Ruan L; Li T
    Open Forum Infect Dis; 2020 Mar; 7(3):ofaa102. PubMed ID: 32258207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential therapeutic approach of intravenous immunoglobulin against COVID-19.
    Kolahchi Z; Sohrabi H; Ekrami Nasab S; Jelodari Mamaghani H; Keyfari Alamdari M; Rezaei N
    Allergy Asthma Clin Immunol; 2021 Oct; 17(1):105. PubMed ID: 34627384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of intravenous human immunoglobulin treatment after plasmapheresis in restoring serum immunoglobulin levels: a preliminary study.
    Moriya Y; Yamaji K; Kanai Y; Tsuda H
    Ther Apher; 2002 Apr; 6(2):154-8. PubMed ID: 11982957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Intravenous Immunoglobulin Plus Plasmapheresis on Antibody-mediated Rejection or Thrombotic Microangiopathy in Iranian Kidney Transplant Recipient.
    Dashti-Khavidaki S; Shojaie L; Hosni A; Khatami MR; Jafari A
    Nephrourol Mon; 2015 May; 7(3):e27073. PubMed ID: 26034746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clinical Course of COVID-19 Pneumonia in a 19-Year-Old Man on Intravenous Immunoglobulin Replacement Therapy for X-Linked Agammaglobulinemia.
    Almontasheri A; Al-Husayni F; Alsuraihi AK; Binyahib H; Albanna AS
    Am J Case Rep; 2021 Feb; 22():e929447. PubMed ID: 33612712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Guillain-Barré syndrome with plasmapheresis or immunoglobulin: our experience from a tertiary care institute in South India.
    Kishore CK; Vijayabhaskar J; Vishnu Vardhan R; Sainaresh VV; Sriramnaveen P; Sridhar AV; Varalaxmi B; Sandeep P; Ram R; Vengamma B; Siva Kumar V
    Ren Fail; 2014 Jun; 36(5):732-6. PubMed ID: 24593239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmapheresis or intravenous immunoglobulin for myasthenia gravis crisis in King Chulalongkorn Memorial Hospital.
    Pittayanon R; Treeprasertsuk S; Phanthumchinda K
    J Med Assoc Thai; 2009 Apr; 92(4):478-82. PubMed ID: 19374297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravenous immunoglobulin therapy for Guillain-Barré syndrome in Japan: changes in treatment after its inclusion in health insurance coverage].
    Nishimoto Y; Yuki N
    Rinsho Shinkeigaku; 2004 Sep; 44(9):633-5. PubMed ID: 15515710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of various therapeutic modalities for Guillain Barré syndrome in Assiut University Children Hospital.
    Mohy-Eldeen ZM; Ahmad AR; Mahran HH; Saad K
    Turk J Pediatr; 2020; 62(6):962-969. PubMed ID: 33372434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection.
    White NB; Greenstein SM; Cantafio AW; Schechner R; Glicklich D; McDonough P; Pullman J; Mohandas K; Boctor F; Uehlinger J; Tellis V
    Transplantation; 2004 Sep; 78(5):772-4. PubMed ID: 15371687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic inflammatory demyelinating polyradiculoneuropathy of childhood: treatment with high-dose intravenous immunoglobulin.
    Vedanarayanan VV; Kandt RS; Lewis DV; DeLong GR
    Neurology; 1991 Jun; 41(6):828-30. PubMed ID: 2046925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential plasmapheresis and intravenous immunoglobulin therapy for refractory myasthenia gravis: case report.
    Yeh JH; Chiu HC
    Ther Apher; 1999 Aug; 3(3):271-4. PubMed ID: 10427628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasmapheresis and immunoglobulin therapy].
    Matsuo H
    Rinsho Shinkeigaku; 2012; 52(11):1051-2. PubMed ID: 23196512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin for acute attacks in neuromyelitis optica spectrum disorders (NMOSD).
    Li X; Tian DC; Fan M; Xiu Y; Wang X; Li T; Jia D; Xu W; Song T; Shi FD; Zhang X
    Mult Scler Relat Disord; 2020 Sep; 44():102325. PubMed ID: 32653803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasmapheresis in patients with myasthenia gravis].
    Konishi T
    Nihon Rinsho; 2008 Jun; 66(6):1165-71. PubMed ID: 18540364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating alloimmune responses with plasmapheresis and IVIG.
    Warren DS; Simpkins CE; Cooper M; Montgomery RA
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Jun; 5(3):215-22. PubMed ID: 15975035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis.
    Liu JF; Wang WX; Xue J; Zhao CB; You HZ; Lu JH; Gu Y
    Ther Apher Dial; 2010 Apr; 14(2):153-60. PubMed ID: 20438536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.